The tests the WHO used and still uses today to claim millions were infected with and/or died of COVID-19 were designed, developed and distributed worldwide without having SARS-CoV-2 virus isolates or original patient specimens.
The COVID-19 tests that were/are used worldwide to diagnose COVID-19 infection don’t detect the SARS-CoV-2 itself.
COVID-19 “tests do not detect the virus itself. Instead, they detect the antibodies produced in response to an infection. Serology tests are also known as antibody tests.”
“Serological tests are not appropriate for diagnosing COVID-19.”
Yet, the WHO, Justin Trudeau‘s minority government and governments worldwide used and are still using those bogus tests to test for/diagnose COVID-19 infection. Because those tests don’t detect SARS-CoV-2 millions were intentionally misdiagnosed so that Germany and the insolvent UN could obtain $billions.
Germany funded COVID-19 test developers stated in a January 2020 published report why the tests don’t detect SARS-CoV-2 and why millions were intentionally misdiagnosed as testing positive for COVID-19.
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
published on 23 Jan 2020
Background: The ongoing outbreak of the recently emerged novel coronavirus (2019-nCoV) poses a challenge for public health laboratories as VIRUS ISOLATES ARE UNAVAILABLE while there is growing evidence that the outbreak is more widespread than initially thought, and international spread through travellers does already occur.
Aim: We aimed to develop and deploy robust diagnostic methodology for use in public health laboratory settings WITHOUT HAVING VIRUS MATERIAL AVAILABLE.
Methods: Here we present a validated diagnostic workflow for 2019-nCoV, its design relying on close genetic relatedness of 2019-nCoV with SARS coronavirus, making use of synthetic nucleic acid technology.
“In the present case of 2019-nCoV, virus isolates or samples from infected patients have so far not become available to the international public health community. We report here on the establishment and validation of a diagnostic workflow for 2019-nCoV screening and specific confirmation, designed in absence of available virus isolates or original patient specimens. Design and validation were enabled by the close genetic relatedness to the 2003 SARS-CoV, and aided by the use of synthetic nucleic acid technology.”
Development of the bogus COVID-19 tests was funded by European Union DG Research through projects Prepare (GA602525), Compare (GA643476), and EVAg (GA653316); by European Union DG SANCO through EVD-LabNet, as well as by the German Ministry of Research through projects RAPID (01KI1723A) and DZIF (301-4-7-01.703).
Germany funded, developed and deployed these bogus COVID-19 test to make $billions. To intentionally misdiagnose a patient for financial gain is a criminal offence – health care fraud.